Sale by Tahir Mahmood of 1992 shares of Applied Molecular

AMTIDelisted Stock  USD 0.33  0.00  0.00%   
Under 56% of Applied Molecular's investor base is looking to short. The analysis of current outlook of investing in Applied Molecular Transport suggests that many traders are alarmed regarding Applied Molecular's prospects. Applied Molecular's investing sentiment shows overall attitude of investors towards Applied Molecular Transport.
  
Filed transaction by Applied Molecular Transpo director. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
Applied insider trading alert for sale of common stock by Tahir Mahmood, the corporate stakeholder, on 4th of October 2023. This event was filed by Applied Molecular Transpo with SEC on 2023-10-04. Statement of changes in beneficial ownership - SEC Form 4

Applied Molecular Fundamental Analysis

We analyze Applied Molecular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied Molecular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied Molecular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Applied Molecular is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Applied Molecular Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Applied Molecular stock to make a market-neutral strategy. Peer analysis of Applied Molecular could also be used in its relative valuation, which is a method of valuing Applied Molecular by comparing valuation metrics with similar companies.

Peers

Applied Molecular Related Equities

FENCFennec Pharmaceuticals   6.71   
0%
100.0%
ALRNAileron Therapeutics   4.07   
0%
60.0%
ANTXAN2 Therapeutics   3.73   
0%
55.0%
ACRVAcrivon Therapeutics,   2.65   
0%
39.0%
TPSTTempest Therapeutics   2.17   
0%
32.0%
IKTInhibikase Therapeutics   0.85   
0%
12.0%
AVTEAerovate Therapeutics   0.75   
0%
11.0%
MNPRMonopar Therapeutics   0.26   
0%
3.0%
RZLTRezolute   1.44   
21.0%
0%
ADAGAdagene   2.20   
32.0%
0%
BPTHBio Path   2.44   
36.0%
0%
BNTCBenitec Biopharma   2.96   
44.0%
0%
SNTISenti Biosciences   3.21   
47.0%
0%
LIPOLipella Pharmaceuticals   5.41   
80.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Applied Stock

If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume